{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04927377",
            "orgStudyIdInfo": {
                "id": "IRB-300007168"
            },
            "organization": {
                "fullName": "University of Alabama at Birmingham",
                "class": "OTHER"
            },
            "briefTitle": "Accessible and Inclusive Diabetes Telecoaching Self-Management Program",
            "officialTitle": "Accessible and Inclusive Diabetes Telecoaching Self-Management Program: Protocol for a Feasibility Study",
            "therapeuticArea": [
                "Other"
            ],
            "study": "accessible-and-inclusive-diabetes-telecoaching-self-management-program"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-10-31",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-09-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-06-04",
            "studyFirstSubmitQcDate": "2021-06-08",
            "studyFirstPostDateStruct": {
                "date": "2021-06-16",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-10-27",
            "lastUpdatePostDateStruct": {
                "date": "2023-10-30",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Mohanraj Thirumalai",
                "investigatorTitle": "Assistant Professor",
                "investigatorAffiliation": "University of Alabama at Birmingham"
            },
            "leadSponsor": {
                "name": "University of Alabama at Birmingham",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to develop and pilot test an accessible and inclusive Artificial Intelligence (AI)-assisted, individualized, family-focused lifestyle modification intervention (AI4DM) for glycemic control in people with disabilities.",
            "detailedDescription": "The AI4DM study will use a two-arm randomized control trial design. Eligible and consented participants will be assigned to one of two groups: 1) AI4DM intervention group with telecoaching support, and 2) attention-control group. The active intervention period will include six months of weekly and bi-weekly telecoaching calls followed by six months of follow-up and technology access, but no telecoaching calls."
        },
        "conditionsModule": {
            "conditions": [
                "Diabete Type 2",
                "Disability Physical"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "maskingDescription": "The principal investigator and biostatistician will be masked to the randomization of the participants into the two treatment groups.",
                    "whoMasked": [
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 90,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "AI4DM Intervention Group",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Behavioral: AI4DM"
                    ]
                },
                {
                    "label": "Attention-control Group",
                    "type": "ACTIVE_COMPARATOR",
                    "interventionNames": [
                        "Behavioral: Attention-control"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "AI4DM",
                    "description": "Those in the AI4DM intervention arm will receive weekly and bi-weekly calls for six months, access to home and online technology, diabetes-related multimedia educational content, a technology package including a voice-assistive device, wireless glucometer, and wrist-worn activity monitor",
                    "armGroupLabels": [
                        "AI4DM Intervention Group"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Attention-control",
                    "description": "Those in the Attention-control Group will receive telecoaching calls at the same frequency of the Intervention Group. Coaching calls will focus on general wellbeing, rather than diabetes-related topics. The Attention-control Group will serve as an untreated comparison group for the Intervention Group.",
                    "armGroupLabels": [
                        "Attention-control Group"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Glycemic Management",
                    "description": "Measured using HbA1c",
                    "timeFrame": "48 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Psychological distress",
                    "description": "Measured using Diabetes Distress Scale (DDS); Minimum score = 1, maximum score = 6; Higher score represents worse outcome",
                    "timeFrame": "48 weeks"
                },
                {
                    "measure": "Diabetes Quality of life",
                    "description": "Measured using the DQoL (Diabetes Quality of Life Measure) Questionnaire; Minimum score =1; maximum score = 5; Higher score represents worse outcome",
                    "timeFrame": "48 weeks"
                },
                {
                    "measure": "Self-efficacy",
                    "description": "Measured using Diabetes Empowerment Scale; Minimum score = 1; maximum score = 5; Higher score represents better outcome",
                    "timeFrame": "48 weeks"
                },
                {
                    "measure": "Family Support",
                    "description": "Measured using the Diabetes Social Support Questionnaire - Family Version (DSSQ-Family); Minimum score = -5 maximum score = 15; Higher score represents better outcome",
                    "timeFrame": "48 weeks"
                },
                {
                    "measure": "Physical Activity",
                    "description": "Measured using Godin leisure-time exercise questionnaire; Minimum score = 0; Maximum score = unknown; Higher score represents better outcome",
                    "timeFrame": "48 weeks"
                },
                {
                    "measure": "Dietary intake",
                    "description": "Measured using The UK Diabetes and Diet Questionnaire",
                    "timeFrame": "48 weeks"
                },
                {
                    "measure": "Medication Adherence",
                    "description": "Measured using the Medication Adherence Rating Scale",
                    "timeFrame": "48 weeks"
                },
                {
                    "measure": "Health Information Technology",
                    "description": "Measured using The eHealth Literacy Scale",
                    "timeFrame": "48 weeks"
                },
                {
                    "measure": "Telehealth Dashboard Usability",
                    "description": "Measured using the System Usability Scale; Maximum item score (Strongly agree) = 5, minimum item score (Strongly disagree) = 1; Higher scores represent better outcomes",
                    "timeFrame": "48 weeks"
                },
                {
                    "measure": "Health Technology Usability",
                    "description": "Measured using the Health Information Usability Evaluation Scale (Health-ITUES)",
                    "timeFrame": "48 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of Type 2 Diabetes Mellitus,\n* Living with a permanent physical disability such as spinal cord injury (SCI), spina bifida, multiple sclerosis, stroke, etc.\n* Ability to converse and read in English\n\nExclusion Criteria:\n\n* Current enrollment in any diabetes-related intervention\n* Severe untreated depression in the past six months\n* Major cardiac event in the past twelve months\n* Uncontrolled blood pressure\n* Resting tachycardia\n* Renal failure\n* Severe peripheral neuropathy\n* Unavailability of a smartphone",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Eric J Evans, PhD",
                    "role": "CONTACT",
                    "phone": "205-934-7189",
                    "email": "evansej@uab.edu"
                },
                {
                    "name": "Mohanraj Thirumalai, PhD",
                    "role": "CONTACT",
                    "phone": "205-934-7189",
                    "email": "mohanraj@uab.edu"
                }
            ],
            "locations": [
                {
                    "facility": "University of Alabama at Birmingham",
                    "status": "RECRUITING",
                    "city": "Birmingham",
                    "state": "Alabama",
                    "zip": "35294",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Eric Evans, PhD",
                            "role": "CONTACT",
                            "phone": "205-975-3270",
                            "email": "evansej@uab.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.52066,
                        "lon": -86.80249
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "26647414",
                    "type": "BACKGROUND",
                    "citation": "Wolff K, Chambers L, Bumol S, White RO, Gregory BP, Davis D, Rothman RL. The PRIDE (Partnership to Improve Diabetes Education) Toolkit: Development and Evaluation of Novel Literacy and Culturally Sensitive Diabetes Education Materials. Diabetes Educ. 2016 Feb;42(1):23-33. doi: 10.1177/0145721715620019. Epub 2015 Dec 7."
                },
                {
                    "pmid": "22232096",
                    "type": "BACKGROUND",
                    "citation": "Ali MK, Echouffo-Tcheugui J, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff (Millwood). 2012 Jan;31(1):67-75. doi: 10.1377/hlthaff.2011.1009."
                },
                {
                    "pmid": "12435261",
                    "type": "BACKGROUND",
                    "citation": "Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002 Nov 20;288(19):2469-75. doi: 10.1001/jama.288.19.2469."
                },
                {
                    "pmid": "11769298",
                    "type": "BACKGROUND",
                    "citation": "Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract. 2001 Nov-Dec;4(6):256-62."
                },
                {
                    "pmid": "34505835",
                    "type": "DERIVED",
                    "citation": "Zengul A, Evans E, Hall A, Qu H, Willig A, Cherrington A, Thirumalai M. Telehealth Behavioral Intervention for Diabetes Management in Adults With Physical Disabilities: Intervention Fidelity Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2021 Sep 10;10(9):e31695. doi: 10.2196/31695."
                },
                {
                    "pmid": "34505831",
                    "type": "DERIVED",
                    "citation": "Evans E, Zengul A, Hall A, Qu H, Willig A, Cherrington A, Thirumalai M. Disability-Inclusive Diabetes Self-management Telehealth Program: Protocol for a Pilot and Feasibility Study. JMIR Res Protoc. 2021 Sep 10;10(9):e31689. doi: 10.2196/31689."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Deidentified data will be submitted to ICPSR.",
            "infoTypes": [
                "ANALYTIC_CODE"
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003924",
                    "term": "Diabetes Mellitus, Type 2"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7119",
                    "name": "Diabetes Mellitus, Type 2",
                    "asFound": "Diabete Type 2",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}